CA Patent

CA2544924A1 — Methods and compositions for treating mcp-1 related pathologies

Assigned to Janssen Biotech Inc · Expires 2005-05-19 · 21y expired

What this patent protects

The present invention relates to methods for treating at least one MCP-1 related condition or pathology, including therapeutic compositions, methods and devices.

USPTO Abstract

The present invention relates to methods for treating at least one MCP-1 related condition or pathology, including therapeutic compositions, methods and devices.

Drugs covered by this patent

Patent Metadata

Patent number: CA2544924A1
Jurisdiction: CA
Classification: —
Expires: 2005-05-19
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Biotech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.